Apurinic apyrimidinic endonuclease redox effector factor-1 (APE1/Ref-1) is involved both in the base excision repair (BER) of DNA lesions and in the eukaryotic transcriptional regulation. APE1/Ref-1 is regulated at both the transcriptional and posttranslational levels, through control of subcellular localization and post-translational modification. In response to stress conditions, several cell types release ATP, which exerts stimulatory effects on eukaryotic cells via the purinergic receptors (P2) family. By using western blot and immunofluorescence analysis on a human tumour thyroid cell line (ARO), we demonstrate that purinergic stimulation by extracellular ATP induces quick cytoplasm to nucleus translocation of the protein at early times and its neosynthesis at later times. Continuous purinergic triggering 
INTRODUCTION
Apurinic apyrimidinic endonuclease redox effector (APE1/ Ref-1) is a protein involved both in the BER pathways of DNA lesions and in the regulation of gene expression as a redox co-activator of different transcription factors, such as Early growth response protein-1 (Egr-1), p53 and AP-1 (1). These activities are located into two functionally distinct domains: the N-terminus is principally devoted to the redox activity while the C-terminus exerts the enzymatic activity on the abasic sites of DNA (2) .
APE1/Ref-1 is regulated at both the transcriptional and post-translational levels. In terms of transcriptional regulation, the effects of reactive oxygen species (ROS), such as H 2 (1) . In particular, the 'primum movens' responsible for APE1/Ref-1 activation is completely unknown. Since APE1/Ref-1 is critical for the survival of mammals (7, 8) , it is important to dissect the signalling pathways responsible for its regulation.
Most reports have localized APE1/Ref-1 into the nucleus, but a growing body of evidence has shown that in some cell types, particularly those with high metabolic or proliferative rates, APE1/Ref-1 can be also cytoplasmic (1, 3, 4, 9) . Interestingly, this is a typical feature of some human tumours (1) , such as the anaplastic thyroid carcinoma and the derived cell line (i.e. ARO cells) (3, 10) .
Generally In response to stress conditions or other stimuli, such as hypoxia, hyperoxia, mechanical stress, cAMP, hypotonic media, vasoactive agents and inflammation, several cell types release ATP via either a non-lytic (11, 12) or a lytic mechanism from necrotic and apoptotic cells, reaching high local concentrations.
Extracellular nucleotides exert stimulatory effects on eukaryotic cells via the P2 family of membrane-bound receptors, which comprises P2Y (G-protein-coupled) and P2X (ligandgated ion channel) receptors. Extracellular ATP improves the mitogenic action of several growth factors in a variety of cell types (13) through the control of transcriptional activators, such as AP-1 (14, 15) and Egr-1 via stimulation of P2Y receptors (16) . These effects are mainly played through the simultaneous increase of two important second messengers, Ca 2+ ions and 1,2 diacylglycerol, a physiological activator of protein kinase C (PKC) (17) . Interestingly, there are strong evidences demonstrating that the mitogenic action of P2Y triggering may be exerted by intracellular ROS generation (18) .
Therefore, in the light of these observations, we tested the hypothesis of whether purinergic triggering may be able to affect APE1/Ref-1 functions by controlling its expression and subcellular localization.
MATERIALS AND METHODS

Cell culture and chemicals
ARO cells were cultured in RPMI medium containing 10% (w/v) fetal bovine serum (FBS), 5 mM glutamine and antibiotics. HOBIT cells were grown in DMEM F-12 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin and 10 mg/ml streptomycin sulfate. MG-63 osteoblast-like cells were grown in DMEM culture medium containing 10% (w/v) FCS, 100 U/ml penicillin and 10 mg/ml streptomycin sulfate. The cells were seeded in 100 mm dishes and grown at 37 C in a humidified atmosphere of 5% (v/v) CO 2 . Both ATP and H 2 O 2 treatments were performed on cells after 48 h of serum starvation and in medium w/o serum. Where indicated, protein neosynthesis was blocked by pre-treatment of the cells for 5 min with cycloheximide (CHX) (15 mg/ml) and for the whole duration of the experiment.
All the chemicals described below were from SigmaAldrich Co. (St Louis, MO) unless otherwise specified.
Preparation of total and nuclear cell extracts
Cell nuclear extracts were prepared as described previously (19) . Briefly, 10 7 cells were washed once with phosphatebuffered saline (PBS) and resuspended in 100 ml of hypotonic lysis buffer A [10 mM HEPES, 10 mM KCl, 0.1 mM MgCl 2 , 0.1 mM EDTA, 2 mg/ml leupeptin, 2 mg/ml pepstatin and 0.5 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.9]. After 10 min, cells were homogenized by 10 strokes with a loose-fitting Dounce homogenizer. Nuclei were collected by centrifugation at 500 · g at 4 C for 5 min in a microcentrifuge. The supernatant was considered as the cytoplasmic fraction. Nuclei were then washed three times with the same volumes of buffer A in order to minimize cytoplasmic contamination. Nuclear proteins were extracted with 100 ml of buffer B (10 mM HEPES, 400 mM NaCl, 1.5 mM MgCl 2 , 0.1 mM EDTA, 2 mg/ml leupeptin, 2 mg/ml pepstatin and 0.5 mM PMSF, pH 7.9). After incubating for 30 min at 4 C, samples were centrifuged at 12 000 · g for 20 min at 4 C. Nuclear extracts were then analysed for protein content (20) and stored at À80 C in aliquots.
Western blot analysis
Aliquots containing 5 mg of both nuclear and cytoplasmic extracts, obtained from ARO cells incubated under different conditions, were electrophoresed onto a 12% SDS-PAGE. Proteins were then transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH). Membranes were saturated by incubation, at 4 C overnight, with 5% non-fat dry milk in PBS/0.1% Tween-20 and then incubated with the polyclonal anti-APE1/Ref-1 antibody (21) for 3 h. After three washes with PBS/0.1% Tween-20, membranes were incubated with an anti-rabbit immunoglobulin coupled to peroxidase (Sigma, St Louis, MO). After 60 min of incubation at room temperature, the membranes were washed three times with PBS/0.1% Tween-20 and the blots were developed using enhanced chemiluminescence procedure (Amersham Pharmacia Biotech, Milan, Italy). Normalizations were performed with the polyclonal anti-actin antibody (Sigma, St Louis, MO). Blots were quantified by using a Gel Doc 2000 videodensitometer (Bio-Rad, Hercules, CA).
For western blot analysis of P2 receptors, 10 6 ARO cells were lysed in 100 ml of lysis buffer containing 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 0.5 mM PMSF, 0.1 mM NaF, 2 mg/ml leupeptin and 2 mg/ml pepstatin in PBS. After incubation for 30 min on ice, cellular extracts were centrifuged at 13 000 g for 15 min at 4 C and the supernatant was collected. Then, 50 mg of extracts were separated onto a 10% SDS-PAGE, blotted onto nitrocellulose membranes and assayed for the presence of P2Y 1 and P2Y 2 proteins by using specific polyclonal antibodies (Alomone Labs., Jerusalem, Israel). To assay for the specificity of the recognized bands, competition experiments, with the specific peptides of the two receptors, were performed by pre-incubating each antibody for 30 min at room temperature with each specific peptide according to manufacturer's instructions before probing the membranes. Membrane blocking and bands detection were performed as described above.
Immunofluorescence and confocal microscopy
Cells were fixed for 20 min with 4% paraformaldehyde in PBS, treated for 5 min with 0.1% Triton X-100 in PBS. Cells were then incubated for 30 min at 37 C with 0.1 mg/ml RNase in PBS. Unspecific binding of the antibodies was blocked for 20 min with 1% FBS in PBS. The primary monoclonal antibody anti-APE1/Ref-1 (22) was incubated for 30 min at room temperature. Fluoresceinated secondary antibody was used to reveal the primary antibody.
After immunofluorescence treatment, nuclei were stained by 3 min incubation in 1 mg/ml solution of propidium iodide in PBS. Inhibition of protein synthesis was carried out by adding CHX 5 min before and during the stimulation time. Immunofluorescent images were collected using a confocal microscope (Leica DM IRB/E, Wetzlar, Germany).
Determination of AP endonuclease activity
The determination of AP endonuclease activity was performed using an oligonucleotide cleavage assay as described previously (6) . Cell extracts were incubated with a 5 0 -32 Pend-labelled 26mer oligonucleotide containing a single tetrahydrofuranyl (THF) artificial AP site at position 14, which, in the presence of AP endonuclease activity, is cleaved to a 14mer. The abasic analogue is resistant to cleavage by 3 0 -acting AP lyase activity, which is generally possessed by DNA glycosylase/AP lyases. Therefore, this assay is specific for APE1/Ref-1 activity in cells. Reaction mixtures (20 ml) containing cell extracts of interest, 2.5 pmol of 5 0 -32 Pend-labelled, double-stranded THF oligonucleotide, 50 mM HEPES, 50 mM KCl, 10 mM MgCl 2 , 1 mg/ml BSA and 0.05% Triton X-100 (pH 7.5) were allowed to proceed for 15 min in a 37 C water bath. Reactions were halted by adding 10 ml of 96% formamide, 10 mM EDTA, xylene cyanol and bromophenol blue as dyes. AP assay products (5 ml) were separated on a 20% polyacrylamide gel containing 7 M urea. Gels were wrapped in saran wrap and exposed to film for autoradiography. The amount of 14mer-26mer was determined by scanning the exposed film into Gel Doc scanner (BioRad, Milan, Italy).
Electrophoretic mobility shift assay (EMSA) analysis of AP-1 DNA-binding activity Double-stranded oligodeoxynucleotides, labelled at the 5 0 end with 32 P, were used as probes in gel retardation assays. The specific AP-1 consensus binding site, here named AP-1 BS oligonucleotide, is a 21mer whose upper strand is 5 0 -CGCTTGATGAGTCAGCCGGAA-3 0 . The mutant AP-1 binding site that was used for competitions, here named AP-1 MS oligonucleotide, is a 21mer whose upper strand is 5 0 -CGCTTGATGACCCAGCCGGAA-3 0 (underlined the mutagenized bases). Both oligonucleotides were from Geneka Biotechnology Inc. (Montreal, Canada). The gel retardation assay was performed by incubating protein and DNA in a buffer containing 20 mM Tris-HCl, pH 7.6, 75 mM KCl, 0.25 mg/ml BSA with calf thymus DNA (25 mg/ml) and 10% glycerol for 30 min at room temperature. Proteinbound DNA and free DNA were separated on a native 5% polyacrylamide gel run in 0.5xTBE for 1.5 h at 4 C. The gel was dried and then exposed to an X-ray film at À80 C. (23) from bacterial extracts and treated as described previously (2) . Sample concentrations were determined by Bradford colorimetric assay (20) . The purified proteins gave a single band on an overloaded SDS-PAGE. Fractions containing purified proteins were stored at À80 C. High-performance liquid chromatography analysis and mass spectrometry characterization confirmed the quality of the purified protein.
Cell viability assay
An MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was used for the cell viability assay (24) . After incubation with H 2 O 2 for 1 h, a 1/10 volume of MTT solution (4 mg/ml in PBS) was added and incubated for 4 h under 10% CO 2 /90% air at 37 C. Then, the supernatant was aspirated and an equal volume of dimethyl sulfoxide was added to the cells; the MTT formazan was dissolved by pipetting. The absorbance was measured on an enzymelinked immunosorbent assay plate reader (EL808 Ultra Microplate Reader BIO-TEK Instruments, Inc., Winooski, VT) with test and reference wavelength of 570 and 630 nm, respectively.
Determination of intracellular ROS levels
Intracellular ROS levels were monitored by using the fluorescent dye 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 DCFDA) (Molecular Probes, Eugene, OR), which is a non-polar compound converted into a non-fluorescent polar derivative (H 2 DCF) by cellular esterases after incorporation into cells. H 2 DCF is membrane impermeable and is oxidized rapidly to the highly fluorescent 2 0 ,7 0 -dichlorofluorescein (DCF) in the presence of intracellular ROS (25) . The day before the experiments, ARO cells were seeded at a density of 40 000 cells/cm 2 . In the day of the experiment, after removing the medium with serum, the cells were washed in the plates with PBS and then incubated in 5% CO 2 /95% air at 37 C with the ATP stimulus. Then, the H 2 DCFDA (10 mM) was added 30 min before finishing cellular treatment. The cells were washed twice with PBS, harvested with trypsin and centrifuged at 800 g for 5 min and finally washed twice in PBS. A spectrofluorometer (LS-50B Perkin Elmer, Wellesley, MA) was used to measure the fluorescence intensity with the excitation and emission wavelengths at 505 and 530 nm, respectively.
RT-PCR analysis
Total RNA was purified from ARO or MG-63 cells using the SV Total RNA Isolation System from Promega (WI, USA) according to the manufacturer's protocol. RT-PCR was performed with 1 mg of total RNA as template. P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 and control GAPDH mRNAs were reverse transcribed using a 20mer oligo(dT) and amplified using the specific primers: P2Y 1 0 -CCACCCATGGCAAATTCCAT-GGCA-3 0 (amplified of 598 bp) (26) . The amplified products were resolved on a 1.5% agarose gel.
Statistical analysis
Statistical analysis was performed using the Microsoft excel data analysis program for Student's t-test analysis or the statistical analysis program for ANOVA with the Scheffè multiple comparison test. P < 0.05 was considered statistically significant. In order to assay for the sensitivity of APE1/Ref-1 nuclear translocation upon ATP stimulation, dose-response experiments were carried out at 10 min of ATP treatment ( Figure 2C, lanes 1-4) . Stimulatory effects were clearly detectable at doses of ATP as low as 10 and 1 mM, thus emphasizing the biological relevance of this phenomenon.
RESULTS
ATP treatment modulates
Purinergic receptors (P1 and P2) are natural candidates as targets for ATP stimulation. To test whether ATP activates P2-type receptors, ARO cells were pre-treated with P2 antagonist (100 mM suramin) 30 min before the addition of 100 mM ATP (27) Adenosine is the main agonist of P1 receptors (27) and it may be present in the medium as a by-product of ATP hydrolysis. Therefore, we performed experiments with the nonhydrolysable form of ATP (i.e. ATP-gS) and with adenosine. Data reported in Figure 2C To infer the class of P2 receptors (P2X or P2Y) that may be responsible for the ATP-induced APE1/Ref-1 nuclear translocation, we performed a series of experiments with P2Y specific agonists, UTP and ADP (27) , being ATP a nonselective agonist of both P2X and P2Y receptors. ARO cells were treated with 100 mM UTP or with 100 mM ADP for 10 min and APE1/Ref-1 amounts were assayed by western blot analysis performed on nuclear and cytoplasmic extracts ( Figure 2D, lanes 3 and 4) . Both UTP and ADP clearly exert a stimulatory effect, comparable with that obtained with ATP treatment ( Figure 2D , lane 2), thus suggesting that P2Y receptors are mainly involved in the ATP-induced APE1/Ref-1 nuclear translocation. Moreover, the specificity of UTP for P2Y 2 receptors (27,28) is suggestive for a major involvement of P2Y 2 over P2Y 1 receptors in mediating the effect of ATP. To strengthen the role of P2Y receptors and to definitely exclude the involvement of P2X receptor class, experiments with the specific agonist of P2Y receptors (i.e. 2MeSADP) and with the specific agonist of P2X receptors (i.e. abMeATP) were performed ( Figure 2D , lanes 5 and 6). While the former promoted an active APE1/Ref-1 nuclear translocation, the latter was completely unable.
Further experiments were carried out to discriminate the different subclasses of P2Y purinoreceptors. Unlike P2Y 1 and P2Y 1 -like receptors, P2Y 2 and P2Y 4 receptors are activated by both ATP and UTP and only weakly by ADP and other nucleoside diphosphates. It is known that P2Y 6 receptor is activated by UDP that, in our experimental conditions, can be present as a contaminant. To exclude the involvement of P2Y 4 and P2Y 6 in our system, we used RT-PCR to assay the expression of these receptors by ARO cells (Figure 2E, left) . Indeed, while P2Y 1 and P2Y 2 are expressed, P2Y 4 and P2Y 6 are not, thus excluding their involvement in the APE1/Ref-1 activation. As a positive control for P2Y 4 and P2Y 6 amplifications, the cDNA of MG-63 cells expressing these two purinoreceptors was used as template. The signal obtained with primers specific for GAPDH was similar in all reactions, confirming the integrity and amount of cDNA in each sample. Western blot analysis, performed with specific antibodies ( Figure 2E to downregulate PKC, and with BAPTA-AM to deplete intracellular Ca 2+ . After the addition of 1 mM H 2 O 2 for 5 min, cytosol and nuclear extracts were prepared and assayed by western blot. We observed that the translocation of APE1/ Ref-1 from cytosol to nucleus was evident in cells stimulated with H 2 O 2 and in the absence of PMA or BAPTA-AM ( Figure 3B , lanes 5 and 6), while in cells treated with these inhibitors the translocation was completely inhibited ( Figure 3B, lanes 1-4) . These results clearly indicate that, similarly to what seen for the ATP-triggering, H 2 O 2 -induced translocation of APE1/Ref-1 is also dependent on PKC and calcium ion. This fact suggests that H 2 O 2 and ATP trigger the same signal transduction pathway and that a linkage may exist between oxidative stress and involvement of purinergictriggering in controlling cell functioning.
ATP stimulation promotes ROS generation in ARO cells through NADPH oxidase, which is required for APE1/Ref-1 cytoplasm to nucleus translocation
It has been recently reported that prostate tumour spheroids may generate intracellular ROS, upon purinergic triggering, by a non-phagocytic NADPH oxidase (18) . Therefore, since APE1/Ref-1 is sensitive to intracellular ROS levels, we hypothesized that ATP-induced APE1/Ref-1 translocation in ARO cells could be mediated by intracellular ROS rise. Thus, we tested the ability of ARO cells to produce intracellular ROS upon purinergic triggering. Indeed, incubation of ARO cells with 100 mM ATP for 10 min significantly increased the levels of intracellular ROS ( Figure 4A) , as evidenced by oxidation of non-fluorescent H 2 DCF to the highly fluorescent oxidation product DCF. To test whether the increase of DCF fluorescence reflects an elevation of intracellular ROS levels, we preincubated ARO cells with the free radical scavenger N-acetyl cysteine (NAC). As it is clear from Figure 4A , 10 mM NAC treatment is able to significantly reduce the relative fluorescence indicating that a generation of intracellular ROS does really occur upon ATP stimulation of the cells.
Several studies indicated a leading role for an NADPH oxidase in generating intracellular ROS in non-phagocytic cells (35) . To investigate the possible involvement of an NADPH oxidase in the ATP-mediated ROS generation, ARO cells were pre-incubated with the specific NADPH oxidase inhibitor diphenylene iodonium chloride (DPI) (36) , and intracellular ROS levels were monitored by the use of the ROS indicator H 2 DCFDA. DPI treatment ( Figure 4A) 2+ chelator BAPTA-AM, ROS generation following ATP was completely blunted and the ROS levels dropped to a value far under the basal level, suggesting that Ca 2+ mobilization is also required for the basal production of intracellular ROS ( Figure 4A ). The intracellular Ca 2+ mobilization, as followed by calcium imaging experiments on fura2-loaded ARO cells, was not abolished in the presence of NAC, suggesting that it does not depend on the generation of intracellular ROS (data not shown). Thus, we can conclude that Ca 2+ mobilization seems to be the most important regulatory mechanism able to control the intracellular ROS production of ARO cells. We, therefore, tested the role of NADPH oxidase with respect to ATP-mediated APE1/Ref-1 cytoplasm to nucleus translocation ( Figure 4B The non-phagocytic NADPH oxidase has been previously demonstrated to be activated by Ca 2+ -activated phospholipase A 2 (PLA 2 ) (18). In order to investigate whether this is also the case in our cell system and whether it is related to APE1/Ref-1 translocation, ARO cells were pre-incubated with PLA 2 inhibitor indomethacin, and ROS generation and APE1/Ref-1 translocation were analysed ( Figure 4C and D, respectively). Indeed PLA 2 inhibition was responsible for blockage of ROS production together with a partial, though significant, inhibition of APE1/Ref-1 cytoplasm to nucleus translocation ( Figure 4D, lanes 5 and 6) .
It has been previously demonstrated, in several cell systems, that extracellular regulated kinases (ERKs) contribute to functionally activate the NADP(H) oxidase by phosphorylating different subunits (37, 38) . In order to check whether ERK-1/2 may also be involved in ATP-induced activation of ROS production and APE1/Ref-1 translocation, both phenomena were analysed. Data are reported in Figure 4C and D. PD98059 (a specific inhibitor of ERK-1/2 phosphorylation) pre-treatment was able to both block intracellular ROS production ( Figure 4C ) and APE1/Ref-1 cytoplasm to nucleus translocation ( Figure 4D, lanes 3 and 4) . Therefore, ERKs signalling is also responsible for the activation of intracellular ROS production by ATP stimulation.
Inhibition of intracellular Ca
2+ mobilization and ROS production block APE1/Ref-1 nuclear translocation and its functional activation
In order to test whether the stimulatory effect of ATP treatment has consequences on APE1/Ref-1 functions, we first tested its DNA repair activity. APE1/Ref-1 enzymatic activities, on nuclear extracts from ARO cells stimulated or not with extracellular ATP, were assayed, as described previously (6) . The assay uses a radiolabelled oligonucleotide (26mer) containing an artificial tetrahydrofuran AP site which, when cleaved by AP endonuclease, produces a labelled 14mer. The same amounts of nuclear extracts from non-stimulated and ATP-stimulated ARO cells were assayed for endonuclease activity and are shown in Figure 5A In order to test whether APE1/Ref-1 activation following ATP stimulation has a functional relevance as a redox modulator, the activity of the well-established redox-regulated transcription factor AP-1 was assessed. ARO cells were treated with CHX as described above and further stimulated for 10 min with 100 mM ATP. Then, nuclear extracts were prepared and assayed for AP-1 DNA-binding activity by EMSA analysis ( Figure 5B 5) and with DPI (lanes 6 and 7) as described in A, respectively. Thereafter, cells were treated for 10 min with 100 mM ATP. Then, cells were collected and lysed to obtain nuclear extracts that were subsequently used for EMSA analysis with the 32 P-labelled specific oligo called AP-1 BS. An aliquot of 5 mg of each nuclear extract was incubated with 200 fmol of labelled probe in the presence of 500 ng of calf thymus DNA as aspecific competitor for 30 min at room temperature and then analysed by native 5% PAGE. After drying, the gel was exposed o/n at À80 C for autoradiography. To test for the specific protein/DNA complex, a competition assay was performed, on ATP-stimulated nuclear extracts, with a molar excess of the cold specific AP-1 BS 6 and 7) . These results clearly demonstrate that either inhibition of intracellular ROS production or Ca (41, 42) . Therefore, we tested whether ATP stimulation was able to protect cells by H 2 O 2 -evoked cell death. ARO cells were stimulated or not for 30 min with 100 mM ATP, in the presence of CHX (15 mg/ml), and treated for an additional 1 h with increasing amounts of H 2 O 2 , and cell viability was then assayed by MTT analysis ( Figure 5C ). H 2 O 2 treatment caused a concentrationdependent decrease in cell viability of ARO cells, due to cell death. When incubated for 1 h with 5 mM H 2 O 2 , the cell viability was almost halved and then gradually decreased to $20% of the non-treated control level. Figure 5C (44) . These authors also showed the existence of nuclear export process responsible for regulating the APE1/ Ref-1 nuclear level. In light of our data, showing that P2-induced signalling plays an important role in controlling nuclear maintenance of the protein, we can hypothesize that this process could be an inhibitory target of P2 pathway here delineated.
We have characterized the mechanisms responsible for the activatory effects on APE1/Ref-1 and found that purinergic signalling is mainly exerted by intracellular ROS production by non-phagocytic NADPH oxidase in a calcium-dependent manner; however, additional MAPK-and/or PKC-dependent mechanisms could also be involved (see Figure 6 ). The involvement of NADPH oxidase in the activation of APE1/ Ref-1 suggests the existence of an autoregulatory loop between these two proteins. In fact, the non-phagocytic NADPH oxidase is an enzyme composed of multiple membrane-associated (Mox and p22 phox ) and cytosolic components (p67 phox , p47 phox , Rac1) and catalyses the transformation of the molecular oxygen to the superoxide anion by transferring an electron from the substrates NADH or NADPH (45) . Moreover, in thyroid cells, it represents the major source of H 2 O 2 necessary for thyroid hormone biosynthesis (46) . Functional activation of this enzyme is controlled by Rac1, a small GTPase exerting regulatory and assembling functions on the oloenzyme itself (47) . It has been recently demonstrated that APE1/Ref-1 may inhibit Rac1 activity in vivo, in different cell models, thus controlling intracellular ROS production (48, 49) . Therefore, we can hypothesize that APE1/Ref-1 may also be involved in extinguishing the NADPH-mediated ROS production induced by P2Y triggering (see Figure 6 ). Work is in progress to address this issue. Since APE1/Ref-1 and NADPH oxidase are ubiquitously expressed, and purinergic triggering is particularly important for endothelial, fibroblastic and smooth muscle cells in the vascular system (50), the present findings may be therapeutically relevant.
At present, receptors for ATP and other nucleotides have been found in almost all cell types and have wide physiological involvement both in normal and in pathological conditions. Though the effects of extracellular nucleotides in endocrine cells are largely unexplored and even if the thyroid gland is mainly regulated by thyrotropin, it is also under regulation by sympathetic and parasympathetic nerves, whose terminals also reach thyroid follicles (51) . Therefore, in principle, ATP released from nerve terminals may also modulate thyroid functions. In particular, investigations in thyroid cell cultures have shown that ATP may act as true agonist being involved in some physiological responses, such as regulation of iodide fluxes and generation of H 2 O 2 (52) and may act as co-mitogen in normal rat FRTL-5 thyroid cell lines (15) through up-regulating the expression of proto-oncogenes, such as c-Fos and the enhancement of DNA-synthesis (53) . In thyroid cells, the molecular mechanism of such activations described a central role for Ca 2+ fluxes evoked by ATP and activation of PLA 2 as consequences of the ATP-induced stimulation of phospholipase C. However, the effects of the interactions of these two pathways, in terms of molecular targets, have not yet been thoroughly investigated in thyroid cells. Interestingly, very recent data demonstrated that transformed thyroid cell lines show disturbances in purinergic Ca 2+ signalling (54) . Whether alteration in purinergic signalling plays a role in tumourigenic process is unknown, at present. Our data, obtained under continuous treatment with apyrase and suramin, showed that purinergic triggering is responsible for the maintenance of high cytoplasmic levels of APE1/Ref-1 protein in the anaplastic tumoural thyroid ARO cell line. These data, together with the observation that ATP stimulation exerts protective role on H 2 O 2 -induced cell death, provide two important suggestions: (i) alterations of the intracellular amounts of APE1/Ref-1 found in several tumours, including thyroid tumours (1), may be due to an imbalance in purinergic receptor signalling system and (ii) purinergic receptors alterations may be an early event occurring during the tumourigenic process and may provide the tumour cell with higher protective mechanisms towards oxidative injuries. In this light, much more attention should be paid in order to better understand the role, if any, of purinergic receptor signalling in controlling specific differentiative steps, as recently demonstrated by the finding that a coordinated expression of several purinergic receptors of different classes occur during skeletal muscle development (55) .
